Publication | Open Access

Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma

AsthmaSevere Persistent AsthmaHealth-related QualityRespiratory FunctionPulmonary PharmacologyPulmonary MedicineAllergic RhinitisMedicine